C&O Launches the First Rabeprazole Sodium for Injection (澳博平®) in China. C&O Launches the First Rabeprazole Sodium for Injection (澳博平®) in China. C&O Pharmaceutical Technology (Holdings) Limited (“C&O” or “We”) was incorporated in 2003 and history of its foundation can trace back to 1997. C&O has been achieving fast development in the rapid growth of China pharmaceutical market throughout these years. In 2011, we joined as the member under Shionogi & Co., Ltd. (“Shionogi” or “the Headquarter”). In the process of the “Headquarter Globalization”, we are playing an important role in China among the huge market activities. Page Updated as at 12/18/19 Please read our General Disclaimer & Warning carefully. Use of this Website constitutes acceptance of the Terms of Website Use. Copyright © 2008. ListedCompany.com. All Rights Reserved.